Articulation disorders and duration, severity and l-dopa dosage in idiopathic Parkinson's disease

Logemann, 1978, Frequency and co occurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients, J Speech Hear Dis, 43, 47, 10.1044/jshd.4301.47 Ho, 2008, For better or worse: the effect of Levodopa on speech in Parkinson's disease, Mov Disord, 23, 574, 10.1002/mds.21899 Ramig, 2008, Speech treatment for Parkinson‘s disease, Expert Rev Neurother, 8, 299, 10.1586/14737175.8.2.297 Yorkston, 2004 Rusz, 2011, Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease, J Acoust Soc Am, 129, 350, 10.1121/1.3514381 Skodda, 2008, Speech rate and rhythm in Parkinson's disease, Mov Disord, 23, 985, 10.1002/mds.21996 Logemann, 1973, The steps in the degeneration of speech and voice control in Parkinson's disease Logemann, 1998 Yahr, 1969, Treatment of parkinsonism with levodopa, Arch Neurol, 21, 343, 10.1001/archneur.1969.00480160015001 Wolfe, 1975, Speech changes in Parkinson's disease during treatment with L-dopa, J Commun Disord, 8, 271, 10.1016/0021-9924(75)90019-2 Solomon, 1993, Speech breathing in Parkinson's disease, J Speech Hear Res, 36, 294, 10.1044/jshr.3602.294 Leanderson, 1971, Effect of L-dopa on speech in parkinsonism: an EMG study of lacbial articulatory function, J Neurol Neurosurg Psychiatry, 34, 679, 10.1136/jnnp.34.6.679 Nakano, 1973, Speech defects of parkinsonian patients: effects of levodopa therapy on speech intelligibility, Neurology, 23, 865, 10.1212/WNL.23.8.865 Rigrodsky, 1970, Speech change in Parkinsonism during L-dopa therapy: preminary findings, J Am Geriatr Sci, 18, 142, 10.1111/j.1532-5415.1970.tb02111.x Skodda, 2012, Impairment of vowel articulation as a possible marker of disease progression in Parkinson's disease, PLOS ONE, 7, e32132, 10.1371/journal.pone.0032132 Cahill, 1998, Effect of oral levodopa treatment on articulatory function in Parkinson's disease: preliminary results, Motor Control, 2, 161, 10.1123/mcj.2.2.161 De Letter, 2007, The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease, Clin Neurol Neurosurg, 109, 495, 10.1016/j.clineuro.2007.04.003 Goberman, 2003, Parkinsonian speech disfluencies: effects of L-dopa-related fluctuations, J Fluency Disord, 28, 55, 10.1016/S0094-730X(03)00005-6 Ho, 2008, For better or for worse: the effect of levodopa on speech in Parkinson's disease, Mov Disord, 23, 574, 10.1002/mds.21899 Perez, 1996, The Parkinson larynx: tremor and videostroboscopic findings, J Voice, 10, 354, 10.1016/S0892-1997(96)80027-0 Liotti, 2003, Hypophonia in Parkinson's disease: neural correlates of voice treatment revealed by PET, Neurology, 60, 432, 10.1212/WNL.60.3.432 Pinto, 2004, Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study, Brain, 127, 602, 10.1093/brain/awh074 2003, The Unified Parkinson's Disease Rating Scale (UPDRS): status and recomendations, Mov Disord, 18, 738, 10.1002/mds.10473 Hoehn, 1967, Parkinsonism: onset, progression and mortality, Neurology, 17, 427, 10.1212/WNL.17.5.427 Enderby, 1983 Shapiro, 1965, An analysis of variance test for nomality (complete samples), Biometics, 52, 591 Mann, 1947, On a test of whether one of two random variables is stochastically larger than the other, Ann Math Stat, 18, 50, 10.1214/aoms/1177730491 Stanisz, 2007 Krysicki, 2006, 230 Ackermann, 1995, Oral diadochokinesis in neurological dysarthrias, Folia Phoniatr Logop, 47, 15, 10.1159/000266338 Canter, 1965, Speech characteristics of patients with Parkinson's disease. II. Physiological supporte for speech, J Speech Hear Dis, 30, 44, 10.1044/jshd.3001.44 Ramig, 1996, Intensive speech treatment for people with Parkinson's disease: short and long term comparison of two techniques, Neurology., 47, 1496, 10.1212/WNL.47.6.1496 Caviness, 2007, Defining mild cognitive impairment in Parkinson's disease, Mov Disord, 22, 1272, 10.1002/mds.21453 Forrest, 1989, Kinematic, acoustic, and perceptual analysis of connected speech produced by parkinsonian and normal geriatric adults, J Acou Soc Am, 85, 2608, 10.1121/1.397755 Dromey, 2003, Spectral measures and perceptual ratings of hypokinetic dysarthria, J Med Speech Lang Pathol, 11, 85 Skodda, 2009, Progression of dysprosody in Parkinson's disease over time—a longitudinal study, Mov Disord, 24, 716, 10.1002/mds.22430 Holmes, 2000, Voice characteristics in the progression of Parkinson's disease, Int J Lang Commun Disord, 35, 407, 10.1080/136828200410654 Tykalova, 2015, Effect of dopaminergic medication on speech dysfluency in Parkinson's disease: a longitudinal study, J Neural Transm, 10.1007/s00702-015-1363-y